Rare cancer study: does surgery help patients live longer?
NCT ID NCT07596654
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times
Summary
This study looks at people with a rare and aggressive type of esophageal cancer that hasn't spread. It compares those who had surgery (with or without other treatments) to those who had non-surgical treatments like chemotherapy and radiation. The goal is to see which approach helps patients live longer and guide future treatment choices.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jinling Hospital, Nanjing, Jiangsu Province, China.
RECRUITINGNanjing, Jiangsu, 210002, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Target antibody shrink Hard-to-Treat cancers?
- New PET tracer could spot cancers that standard scans overlook
- Massive study sheds light on esophageal cancer surgery outcomes
- New hope for advanced cancer patients as experimental drug enters human testing.
- When to treat? new trial aims to optimize therapy for oligometastatic esophageal and gastric cancer
- Personalized blood test aims to track stomach and colon cancer spread